Chemotherapy of drug-resistant malaria

Canadian Journal of Infectious Diseases

Volumn 7, Issue 1, 1996, Pages 25-33

  Kain, Kevin C ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Drug resistant malaria; Plasmodium falciparum; Plasmodium vivax

Indexed keywords

ARTEMETHER; ARTEMISIN DERIVATIVE; ARTESUNATE; ATOVAQUONE; CHLOROQUINE; CLINDAMYCIN; HALOFANTRINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUINIDINE GLUCONATE; QUININE; QUININE SULFATE; SULFADOXINE;

DIARRHEA; HUMAN; INFORMATION RETRIEVAL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MALARIA FALCIPARUM; MEDICAL INFORMATION; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RASH; REVIEW;

EID: 0029976324     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1996/139612     Document Type: Review

References (61)

1. Campbell CC. Challenges facing antimalarial therapy in Africa. J Infect Dis 1991;163:1207-11.
2. Miller L. The challenge of malaria. Science 1992;257:36-7.
3. Malaria. Wkly Epidemiol Rec 1992;67:349-50.
4. Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States. Washington: National Academy Press, 1992.
5. Bouma MJ, Sondorp HE, van der Kaay HJ. Health and climate Change. Lancet 1994;343:302.
6. Loevinsohn ME. Climatic warming and increased malaria incidence in Rwanda. Lancet 1994;343:714-8.
7. Bouma MJ, Sondorp HE, van der Kaay HJ. Climate change and periodic epidemic malaria. Lancet 1994;343:1440.
8. Molyneux M, Fox R. Diagnosis and treatment of malaria in Britain. BMJ 1993;306:1175-80.
9. Freedman DO. Imported malaria - here to stay. Am J Med 1992;93:239-42.
10. Hoffman SL. Diagnosis, treatment and prevention of malaria. Med Clin North Am 1992;76:1327-55.
11. Malaria surveillance annual summary. Can Dis Wkly Rep 1989;15:199-204.
12. Wittes RC. Recent Canadian deaths from malaria acquired in Africa. Can Dis Wkly Rep 1989;15:199.
13. Winters RA, Murray HW. Malaria - the mime revisited: fifteen more years of experience at a New York City teaching hospital. Am J Med 1992;93:243-6.
14. Kain KC, Tennyson S, Harrington MA, Keystone JS. Imported malaria in Toronto: prospective evaluation of 83 cases over 10 months. Fourth International Conference on Travel Medicine. Acapulco, April 23 to 27, 1995. (Abst 177)
15. Warrell D, Molyneux M, Beales P. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84:1-65.
16. Nosten F, ter Kuile R, Chongsuphajaisiddhi T, et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1991;337:1140-3.
17. Brasseur P, Kouamouo J, Moyou RS, et al. Emergence of mefloquine-resistant malaria in Africa without drug pressure. Lancet 1990;336:59.
18. Raccurt CP, Dumestre-Toulet V, Abraham E, et al. Failure of falciparum prophylaxis by mefloquine in travelers from West Africa. Am J Trop Med Hyg 1991;45:319-24.
19. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanota S, White NJ. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994;88:324-7.
20. Bloland P, Were J, Campbell C. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 1993;167:932-7.
21. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 1994;169:467-70.
22. Slater A, Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 1992;355:167-9.
23. Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature 1995;374:269-71.
24. Krogstad D, Gluzman I, Kyle D, et al. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 1987;238:1283-5.
25. Krogstad D, Gluzman D, Herwaldt B, Schlesinger P, Wellems T. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol 1992;43:57-62.
26. Kyle D, Milhous W, Rossan R. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian aotus monkeys. Am J Trop Med Hyg 1993;48:126-33.
27. Warsame M, Wernsdorfer W, Bjorkman A. Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. Trans R Soc Trop Med Hyg 1992;86:235-6.
28. White N. Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol 1992;34:1-10.
29. Phillips R, Looareesuwan S, Molyneux M, Hatz C, Warrel D. Hypoglycemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin. Q J Med 1993;86:233-40.
30. Wongsrichanalai C, Webster HK, Wimonwattrawatee T, et al. Emergence of multidrug resistant Plasmodium falciparum in Thailand: in vitro tracking. Am J Trop Med Hyg 1992;47:112-6.
31. Looareesuwan S, Wilairatana P, Vanijanonta S, Kyle D, Webster K. Efficacy of quinine-tetracycline for acute uncomplicated felciparum malaria in Thailand. Lancet 1992;339:369.
32. Wilson C, Volkman S, Thaithong S, et al. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 1993;57:151-60.
33. Peel S, Merritt S, Handy J, Baric R. Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. Am J Trop Med Hyg 1993;48:385-97.
34. Lobel H, Miani M, Eng T, Bernard K, Hightower A, Campbell C. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-51.
35. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993;341:1299-303.
36. ter Kuile F, Nosten F, Thieren M, et al. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis 1992;166:1393-400.
37. White NJ. Mefloquine. BMJ 1994;308:286-7.
38. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991;45:86-91.
39. Nosten F, ter Kuile F, Maelankiri L, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994;169:595-603.
40. Keystone JS, Kain KC. Mefloquine dangers - fact or fancy? Can J Infect Dis 1995;6:14-5.
41. Looareesuwan S, Viravan C, Vanijanonta P, et al. Randomized trail of mefloquine-doxycycline and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1994;50:784-9.
42. ter Kuile F, Golan G, Nosten F, et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 1993;341:1044-9.
43. Nosten F, ter Kuile F, Luxemburger C, et al. Cardiac effects of antimalarial treatment of halofantrine. Lancet 1993;341:1054-6.
44. WHO drug alert: halofantrine. Wkly Epidemiol Rec 1993;37:1-2.
45. Klayman D. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228:1049-55.
46. Brewer TG, Peggins JO, Grate SJ, et al. Neurotoxiciry in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 1994;88:33-6.
47. Hien T, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992;86:582-3.
48. White N, Waller D, Crawley J, et al. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet 1992;339:317-21.
49. Taylor T, Wills B, Kazembre P, et al. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet 1993;341:661-2.
50. Looareesuwan S, Kyle D, Virvan C, et al. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Am J Trop Med Hyg 1992;47:794-9.
51. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 1992;339:821-4.
52. Hien TT, Arnold K, Hung NT, et al. Single-dose artemisininmefloquine treatment for acute uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1994;88:688-91.
53. Posner GH, Oh CH, Webster HK, Ager AL, Rosson RN. New, antimalarial, tricyclic 1,2,4-trioxanes: evaluations in mice and monkeys. Am J Trop Med Hyg 1994;50:522-6.
54. Hudson AT, Dickins M, Ginger CD, et al. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res 1991;17:427-35.
55. Looareesuwan S, Viravan C, Webster HK, et al. Clinical studies of atovaquone, alone in or combination with other antimalarial drugs. Am J Trop Med Hyg. (In press)
56. Canfleld CJ, Milhous WK, Ager AL, et al. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists. Am J Trop Med Hyg 1993;49:121-6.
57. Murphy G, Basri H, Purnomo E, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993;341:96-100.
58. Baird JK, Basri H, Subianto B, et al. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 1995;171:1678-82.
59. Smoak BL, Defraites RF, Magill AJ, Wellde BT. Malaria among US Army soldiers returning from Operation Restore Hope: Evidence for primaquine-resistant P. vivax infections. 43rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Cincinnati, November 13 to 17, 1994. (Abst 21)
60. Canadian recommendations for the prevention and treatment of malaria among international travellers. Can Dis Wkly Rep. (In press)
61. Sturchler D, Mittelholzer ML, Kerr L How frequent are notified severe cutaneous adverse reactions to Fansidar? Drug Saf 1993;8:160-8.